Related articles

Artesunate, a derivative of artemisinin extracted from the plant Artemisia annua, is traditionally known for its anti-malarial properties. However, recent studies suggest that IV artesunate possesses potential anti-cancer effects. Used as an adjunct therapy in integrative oncology, it has gained interest due to its selective toxicity against cancer cells. This article explores the scientific mechanisms, clinical evidence, and therapeutic potential of IV artesunate for cancer patients.

Curcumin, the active compound in turmeric (Curcuma longa), is widely recognized for its anti-inflammatory, antioxidant, and anti-cancer properties. While oral curcumin supplements offer health benefits, their bioavailability is limited due to poor absorption and rapid metabolism. Intravenous (IV) curcumin overcomes this limitation by delivering higher concentrations directly into the bloodstream, making it a promising adjunct therapy in cancer treatment. This article explores the scientific mechanisms, clinical evidence, and potential benefits of IV curcumin for cancer patients.

Hyperthermia, or therapeutic heat therapy, involves raising the temperature of tumor tissues to enhance cancer treatment. Research shows that hyperthermia can increase the effectiveness of chemotherapy, radiation therapy, and immunotherapy while directly inducing cancer cell death. This article explores the scientific mechanisms, clinical evidence, and therapeutic potential of hyperthermia for cancer patients.

Oxyhydrogen gas (HHO), a mixture of hydrogen (H₂) and oxygen (O₂) gases, has gained attention in integrative oncology due to its potential antioxidant, antiinflammatory, and anticancer properties. Research suggests that inhaling oxyhydrogen gas may help reduce oxidative stress, modulate immune responses, and enhance overall cellular function. This article explores the scientific mechanisms, clinical evidence, and potential benefits of oxyhydrogen gas therapy for cancer patients.